Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
Alport syndrome inevitably leads to end-stage renal disease and there are no therapies known to improve outcome. Here we determined whether angiotensin-converting enzyme inhibitors can delay time to dialysis and improve life expectancy in three generations of Alport families. Patients were categoriz...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2012
|
| In: |
Kidney international
Year: 2011, Jahrgang: 81, Heft: 5, Pages: 494-501 |
| ISSN: | 1523-1755 |
| DOI: | 10.1038/ki.2011.407 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1038/ki.2011.407 Verlag, kostenfrei, Volltext: http://www.sciencedirect.com/science/article/pii/S0085253815553301 
|
| Verfasserangaben: | Oliver Gross, Christoph Licht, Hans J. Anders, Bernd Hoppe, Bodo Beck, Burkhard Tönshoff, Britta Höcker, Simone Wygoda, Jochen H.H. Ehrich, Lars Pape, Martin Konrad, Wolfgang Rascher, Jörg Dötsch, Dirk E. Müller-Wiefel, Peter Hoyer, and Study Group Members of the Gesellschaft für Pädiatrische Nephrologie (GPN), Bertrand Knebelmann, Yves Pirson, Jean-Pierre Grunfeld, Patrick Niaudet, Pierre Cochat, Laurence Heidet, Said Lebbah, Roser Torra, Tim Friede,Katharina Lange, Gerhard A. Müller and Manfred Weber |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1576196208 | ||
| 003 | DE-627 | ||
| 005 | 20220814155925.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180608r20122011xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/ki.2011.407 |2 doi | |
| 035 | |a (DE-627)1576196208 | ||
| 035 | |a (DE-576)506196208 | ||
| 035 | |a (DE-599)BSZ506196208 | ||
| 035 | |a (OCoLC)1341011036 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Gross, Oliver |e VerfasserIn |0 (DE-588)1072305860 |0 (DE-627)827125836 |0 (DE-576)433748230 |4 aut | |
| 245 | 1 | 0 | |a Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy |c Oliver Gross, Christoph Licht, Hans J. Anders, Bernd Hoppe, Bodo Beck, Burkhard Tönshoff, Britta Höcker, Simone Wygoda, Jochen H.H. Ehrich, Lars Pape, Martin Konrad, Wolfgang Rascher, Jörg Dötsch, Dirk E. Müller-Wiefel, Peter Hoyer, and Study Group Members of the Gesellschaft für Pädiatrische Nephrologie (GPN), Bertrand Knebelmann, Yves Pirson, Jean-Pierre Grunfeld, Patrick Niaudet, Pierre Cochat, Laurence Heidet, Said Lebbah, Roser Torra, Tim Friede,Katharina Lange, Gerhard A. Müller and Manfred Weber |
| 264 | 1 | |c 2012 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online 14 December 2011 | ||
| 500 | |a Gesehen am 08.06.2018 | ||
| 520 | |a Alport syndrome inevitably leads to end-stage renal disease and there are no therapies known to improve outcome. Here we determined whether angiotensin-converting enzyme inhibitors can delay time to dialysis and improve life expectancy in three generations of Alport families. Patients were categorized by renal function at the initiation of therapy and included 33 with hematuria or microalbuminuria, 115 with proteinuria, 26 with impaired renal function, and 109 untreated relatives. Patients were followed for a period whose mean duration exceeded two decades. Untreated relatives started dialysis at a median age of 22 years. Treatment of those with impaired renal function significantly delayed dialysis to a median age of 25, while treatment of those with proteinuria delayed dialysis to a median age of 40. Significantly, no patient with hematuria or microalbuminuria advanced to renal failure so far. Sibling pairs confirmed these results, showing that earlier therapy in younger patients significantly delayed dialysis by 13 years compared to later or no therapy in older siblings. Therapy significantly improved life expectancy beyond the median age of 55 years of the no-treatment cohort. Thus, Alport syndrome is treatable with angiotensin-converting enzyme inhibition to delay renal failure and therapy improves life expectancy in a time-dependent manner. This supports the need for early diagnosis and early nephroprotective therapy in oligosymptomatic patients. | ||
| 534 | |c 2011 | ||
| 650 | 4 | |a Alport syndrome | |
| 650 | 4 | |a chronic kidney disease | |
| 650 | 4 | |a fibrosis | |
| 650 | 4 | |a nephroprotection | |
| 650 | 4 | |a renal insufficiency | |
| 700 | 1 | |a Tönshoff, Burkhard |e VerfasserIn |0 (DE-588)1032445823 |0 (DE-627)738463493 |0 (DE-576)173494196 |4 aut | |
| 700 | 1 | |a Höcker, Britta |d 1974- |e VerfasserIn |0 (DE-588)122785673 |0 (DE-627)706042816 |0 (DE-576)293419795 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Kidney international |d New York, NY : Elsevier, 1972 |g 81(2012), 5, Seite 494-501 |h Online-Ressource |w (DE-627)32046637X |w (DE-600)2007940-0 |w (DE-576)091143004 |x 1523-1755 |7 nnas |a Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy |
| 773 | 1 | 8 | |g volume:81 |g year:2012 |g number:5 |g pages:494-501 |g extent:8 |a Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/ki.2011.407 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0085253815553301 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180608 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 122785673 |a Höcker, Britta |m 122785673:Höcker, Britta |d 910000 |d 910500 |e 910000PH122785673 |e 910500PH122785673 |k 0/910000/ |k 1/910000/910500/ |p 7 | ||
| 998 | |g 1032445823 |a Tönshoff, Burkhard |m 1032445823:Tönshoff, Burkhard |d 910000 |d 910500 |e 910000PT1032445823 |e 910500PT1032445823 |k 0/910000/ |k 1/910000/910500/ |p 6 | ||
| 999 | |a KXP-PPN1576196208 |e 301224364X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Published online 14 December 2011","Gesehen am 08.06.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1576196208","language":["eng"],"title":[{"title_sort":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy"}],"person":[{"role":"aut","display":"Gross, Oliver","roleDisplay":"VerfasserIn","given":"Oliver","family":"Gross"},{"display":"Tönshoff, Burkhard","roleDisplay":"VerfasserIn","role":"aut","family":"Tönshoff","given":"Burkhard"},{"given":"Britta","family":"Höcker","role":"aut","roleDisplay":"VerfasserIn","display":"Höcker, Britta"}],"physDesc":[{"extent":"8 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2007940-0"],"eki":["32046637X"],"issn":["1523-1755"]},"origin":[{"dateIssuedDisp":"1972-","dateIssuedKey":"1972","publisher":"Elsevier ; Blackwell ; Wiley-Blackwell ; Nature Publishing Group","publisherPlace":"New York, NY ; Oxford [u.a.] ; [Erscheinungsort nicht ermittelbar] ; Basingstoke"}],"recId":"32046637X","language":["eng"],"corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"International Society of Nephrology"}],"note":["Gesehen am 20.08.20"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancyKidney international","part":{"pages":"494-501","issue":"5","year":"2012","extent":"8","volume":"81","text":"81(2012), 5, Seite 494-501"},"pubHistory":["1.1972 -"],"title":[{"title":"Kidney international","subtitle":"official journal of the International Society of Nephrology","title_sort":"Kidney international"}]}],"origin":[{"dateIssuedDisp":"2012","dateIssuedKey":"2012"}],"id":{"eki":["1576196208"],"doi":["10.1038/ki.2011.407"]},"name":{"displayForm":["Oliver Gross, Christoph Licht, Hans J. Anders, Bernd Hoppe, Bodo Beck, Burkhard Tönshoff, Britta Höcker, Simone Wygoda, Jochen H.H. Ehrich, Lars Pape, Martin Konrad, Wolfgang Rascher, Jörg Dötsch, Dirk E. Müller-Wiefel, Peter Hoyer, and Study Group Members of the Gesellschaft für Pädiatrische Nephrologie (GPN), Bertrand Knebelmann, Yves Pirson, Jean-Pierre Grunfeld, Patrick Niaudet, Pierre Cochat, Laurence Heidet, Said Lebbah, Roser Torra, Tim Friede,Katharina Lange, Gerhard A. Müller and Manfred Weber"]}} | ||
| SRT | |a GROSSOLIVEEARLYANGIO2012 | ||